183 related articles for article (PubMed ID: 27851713)
1. A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy.
Gillis J; Loutfy M; Bayoumi AM; Antoniou T; Burchell AN; Walmsley S; Cooper C; Klein MB; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Hogg R; Raboud J;
J Acquir Immune Defic Syndr; 2016 Dec; 73(5):531-539. PubMed ID: 27851713
[TBL] [Abstract][Full Text] [Related]
2. CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.
Fairlie L; Karalius B; Patel K; van Dyke RB; Hazra R; Hernán MA; Siberry GK; Seage GR; Agwu A; Wiznia A;
AIDS; 2015 Oct; 29(16):2109-19. PubMed ID: 26182197
[TBL] [Abstract][Full Text] [Related]
3. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
Loutfy MR; Genebat M; Moore D; Raboud J; Chan K; Antoniou T; Milan D; Shen A; Klein MB; Cooper C; Machouf N; Rourke SB; Rachlis A; Tsoukas C; Montaner JS; Walmsley SL; Smieja M; Bayoumi A; Mills E; Hogg RS;
J Acquir Immune Defic Syndr; 2010 Dec; 55(4):451-9. PubMed ID: 21105259
[TBL] [Abstract][Full Text] [Related]
4. A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada.
Benoit AC; Younger J; Beaver K; Jackson R; Loutfy M; Masching R; Nobis T; Nowgesic E; O'Brien-Teengs D; Whitebird W; Zoccole A; Hull M; Jaworsky D; Rachlis A; Rourke S; Burchell AN; Cooper C; Hogg R; Klein MB; Machouf N; Montaner J; Tsoukas C; Raboud J; ;
Antivir Ther; 2017; 22(4):325-335. PubMed ID: 27925609
[TBL] [Abstract][Full Text] [Related]
5. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.
Bouteloup V; Sabin C; Mocroft A; Gras L; Pantazis N; Le Moing V; d'Arminio Monforte A; Mary-Krause M; Roca B; Miro JM; Battegay M; Brockmeyer N; Berenguer J; Morlat P; Obel N; De Wit S; Fätkenheuer G; Zangerle R; Ghosn J; Pérez-Hoyos S; Campbell M; Prins M; Chêne G; Meyer L; Dorrucci M; Torti C; Thiébaut R;
HIV Med; 2017 Jan; 18(1):33-44. PubMed ID: 27625009
[TBL] [Abstract][Full Text] [Related]
6. Disparities in Initiation of Combination Antiretroviral Treatment and in Virologic Suppression Among Patients in the HIV Outpatient Study, 2000-2013.
Novak RM; Hart RL; Chmiel JS; Brooks JT; Buchacz K;
J Acquir Immune Defic Syndr; 2015 Sep; 70(1):23-32. PubMed ID: 25886926
[TBL] [Abstract][Full Text] [Related]
7. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
8. Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy.
Szadkowski L; Tseng A; Walmsley SL; Salit I; Raboud JM
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1579-83. PubMed ID: 22734840
[TBL] [Abstract][Full Text] [Related]
9. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
[TBL] [Abstract][Full Text] [Related]
10. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
[TBL] [Abstract][Full Text] [Related]
11. The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children.
Soeters HM; Sawry S; Moultrie H; Rie AV
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):136-44. PubMed ID: 25072611
[TBL] [Abstract][Full Text] [Related]
12. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).
Oyomopito R; Lee MP; Phanuphak P; Lim PL; Ditangco R; Zhou J; Sirisanthana T; Chen YM; Pujari S; Kumarasamy N; Sungkanuparph S; Lee CK; Kamarulzaman A; Oka S; Zhang FJ; Mean CV; Merati T; Tau G; Smith J; Li PC;
HIV Med; 2010 Sep; 11(8):519-29. PubMed ID: 20345881
[TBL] [Abstract][Full Text] [Related]
13. The Use of Multistate Models to Examine Associations of Stress and Adherence With Transitions Among HIV Care States Observed in a Clinical HIV Cohort.
Blitz S; Antoniou T; Burchell A; Walmsley S; Light L; Gardner S; Rourke S; Cooper C; Kendall C; Loutfy M; Rachlis A; Wobeser W; Benoit A; Raboud J
J Acquir Immune Defic Syndr; 2017 Nov; 76(3):303-310. PubMed ID: 28700406
[TBL] [Abstract][Full Text] [Related]
14. Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study.
King E; Kinvig K; Steif J; Qiu AQ; Maan EJ; Albert AY; Pick N; Alimenti A; Kestler MH; Money DM; Lester RT; Murray MCM
J Med Internet Res; 2017 Jun; 19(6):e190. PubMed ID: 28572079
[TBL] [Abstract][Full Text] [Related]
15. Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes.
Lima VD; Reuter A; Harrigan PR; Lourenço L; Chau W; Hull M; Mackenzie L; Guillemi S; Hogg RS; Barrios R; Montaner JS
AIDS; 2015 Sep; 29(14):1871-82. PubMed ID: 26165354
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
[TBL] [Abstract][Full Text] [Related]
17. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.
Zhou J; Sirisanthana T; Kiertiburanakul S; Chen YM; Han N; Lim PL; Kumarasamy N; Choi JY; Merati TP; Yunihastuti E; Oka S; Kamarulzaman A; Phanuphak P; Lee CK; Li PC; Pujari S; Saphonn V; Law MG
BMC Infect Dis; 2010 Dec; 10():361. PubMed ID: 21182796
[TBL] [Abstract][Full Text] [Related]
18. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
[TBL] [Abstract][Full Text] [Related]
19. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
[TBL] [Abstract][Full Text] [Related]
20. Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.
Pantazis N; Papastamopoulos V; Paparizos V; Metallidis S; Adamis G; Antoniadou A; Psichogiou M; Chini M; Sambatakou H; Sipsas NV; Gogos C; Chrysos G; Panagopoulos P; Katsarou O; Gikas A; Touloumi G;
AIDS; 2019 Aug; 33(10):1645-1655. PubMed ID: 31305332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]